Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/1998
09/03/1998WO1998028423A3 Compositions and methods of use for osteoclast inhibitory factors
09/03/1998WO1998025574A3 Stimulation of an immune response to differentiation antigen stimulated by altered antigen
09/03/1998WO1998024910A3 Mutants of streptococcal toxin c and methods of use
09/03/1998WO1998016205A3 Stable glassy state powder formulations
09/03/1998DE19709148C1 Verfahren zur Herstellung eines Impfstoffes gegen infektiöse Erreger A process for the preparation of a vaccine against infectious agents
09/03/1998CA2283107A1 A tm4sf human tumor-associated antigen
09/03/1998CA2282736A1 Novel human transmembrane 4 superfamily protein
09/03/1998CA2282557A1 Physiologically active protein originating in mammals
09/03/1998CA2252942A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use
09/03/1998CA2252790A1 Novel processes implementing selective immune down regulation (sidr)
09/03/1998CA2247072A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof
09/03/1998CA2198988A1 P28 bap31 a bcl-2 associated protein and use thereof for the modulation of apoptosis
09/02/1998EP0861900A1 Immunological detection of prions
09/02/1998EP0861899A1 LicA polypeptides from Sreptococcus pneumoniae
09/02/1998EP0861898A1 Rat Cathepsin K polynucleotide & polypeptide sequence
09/02/1998EP0861896A2 Cell volume regulated human kinase h-sgk
09/02/1998EP0861895A2 aroE shikimate 5 dehydrogenase from Staphylococcus Aureus
09/02/1998EP0861892A1 Stress protein epitopes
09/02/1998EP0861891A1 Compounds for modulating cell negative regulations and biological applications thereof
09/02/1998EP0861890A1 LicC polypeptides from Streptococcus pneumoniae
09/02/1998EP0861889A1 LicD2 polypeptides from Streptococcus pneumoniae
09/02/1998EP0861850A1 Tumor necrosis related receptor, TR4
09/02/1998EP0861665A1 Infectious bursitis vaccine
09/02/1998EP0861664A2 Vaccine against Lyme disease
09/02/1998EP0861440A1 Recombinant proteins having multiple disulfide bonds and thiol-substituted conjugates thereof
09/02/1998EP0861324A1 Polyvalent anti-dengue vaccine
09/02/1998EP0861319A1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx
09/02/1998EP0861261A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
09/02/1998EP0861093A1 Non-invasive localization of a light-emitting conjugate in a mammal
09/02/1998EP0861091A1 Immunotoxin containing a disulfide-stabilized antibody fragment
09/02/1998EP0861090A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents
09/02/1998EP0861027A1 IceA GENE AND RELATED METHODS
09/02/1998EP0705276B1 Prostaglandin receptor fp and dna encoding it
09/02/1998EP0698091B1 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
09/02/1998EP0686044B1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors
09/02/1998EP0636173B1 Treatment of hiv-associated immune thrombocytopenic purpura
09/02/1998EP0606217B1 Ctl4a receptor, fusion proteins containing it and uses thereof
09/02/1998EP0594610B1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE
09/02/1998CN1192245A Use of gram-positive bacteria to express recombinant proteins
09/02/1998CN1192241A Streptococcal heat shock proteins members of the HSP70 family
09/02/1998CN1192240A Recombinant mistletoe lectin (rML)
09/02/1998CN1192156A Treatment of T cell mediated autoimmune disorders
09/02/1998CN1192153A aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies
09/01/1998US5801234 Polynucleotide encoding saliva binding protein
09/01/1998US5801227 Antibodies to CD40
09/01/1998US5801200 Methods and materials for the diagnosis and treatment of conditions such as stroke
09/01/1998US5801157 Plasmid contained in oil in water or water in oil emulsion and comprising protein, glycoprotein or peptide
09/01/1998US5801142 Human mts-1 protein
09/01/1998US5801044 Nucleic acid encoding an antibody that inhibits cell adhesion protein-carbohydrate interactions
09/01/1998US5801042 Dna and nucleic acids for herpesvirus glycoprotein h, plasmids and genomes
09/01/1998US5801037 Expression of signal-peptide-free staphylokinases
09/01/1998US5801018 Vaccines for Actinobacillus pleuropneumoniae
09/01/1998US5801014 Growth differentiation factor-5
09/01/1998US5801005 Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
09/01/1998US5800991 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics
09/01/1998US5800988 Cdna libraries with nucleotide sequences coded for immunoglobulins with polypeptide chains
09/01/1998US5800981 Human cytomegalovirus antigen and its use
09/01/1998US5800980 Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization
09/01/1998US5800828 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
09/01/1998US5800822 Tandem synthetic HIV-1 peptides
09/01/1998US5800821 Bacterial spores as a heat stable vaccine delivery system
09/01/1998US5800810 Human IL-2 as a vaccine adjuvant
09/01/1998CA2069501C Monoclonal antibody which distinguishes helper inducer and suppressor inducer cd4+ lymphocytes
09/01/1998CA1340018C Monoclonal antibodies reactive with cachetin
08/1998
08/28/1998CA2230497A1 Novel lica
08/28/1998CA2230490A1 Novel licc
08/28/1998CA2230478A1 Novel licd2
08/28/1998CA2230473A1 Novel licd1
08/28/1998CA2230467A1 Novel licb
08/27/1998WO1998037224A1 Transgenically produced non-secreted proteins
08/27/1998WO1998037216A1 Recombinant chimeric viruses and uses thereof
08/27/1998WO1998037210A1 Immunological detection of prions
08/27/1998WO1998037199A1 Novel human mlf3 protein
08/27/1998WO1998037198A1 Human sodium-dependent phosphate cotransporter
08/27/1998WO1998037195A1 Morphogenic proteins
08/27/1998WO1998037192A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes
08/27/1998WO1998037178A1 Immunomodulatory polypeptides derived from the invariant chain of mhc class ii
08/27/1998WO1998037177A1 Isolated viable parasite intestinal cells
08/27/1998WO1998037099A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics
08/27/1998WO1998037098A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
08/27/1998WO1998037095A2 Recombinant pox virus for immunization against muc1 tumor-associated antigen
08/27/1998WO1998037093A2 Compounds for immunotherapy of prostate cancer and methods for their use
08/27/1998WO1998037089A2 Matrix derived anti-hiv peptides and transdominant proteins
08/27/1998WO1998037085A1 Netrin receptors
08/27/1998WO1998036778A1 Sustained drug delivery and compositions useful therefor
08/27/1998WO1998036772A1 Chelating immunostimulating complexes
08/27/1998WO1998036771A1 Method for the production of vaccines against cell surface proteins
08/27/1998WO1998036769A1 Pulsatile delivery of leptin receptor ligands
08/27/1998WO1998036763A1 Treatment of infertility with leptin receptor ligands
08/27/1998WO1998036762A1 Method of modulating hypothalamic somatostatin release
08/27/1998WO1998021231A3 Streptococcus uberis lactoferrin-binding protein
08/27/1998WO1998017814A3 Gene expression and delivery systems and uses
08/27/1998CA2742641A1 Compounds for immunotherapy of prostate cancer and methods for their use
08/27/1998CA2615918A1 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
08/27/1998CA2282859A1 Method for the production of vaccines against cell surface proteins
08/27/1998CA2282501A1 Sustained drug delivery and compositions useful therefor
08/27/1998CA2282325A1 Pulsatile delivery of leptin receptor ligands
08/27/1998CA2282323A1 Method of modulating hypothalamic somatostatin release
08/27/1998CA2282302A1 Morphogenic proteins
08/27/1998CA2281949A1 Transgenically produced non-secreted proteins
1 ... 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 ... 1823